PHU TRUONG, MD
Hematology & Oncology Physician · WICHITA, KS
Individual Active NPI 1558323758
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,175 | 477,106 | $34,998,318 | $10,109,199 | $8,051,139 |
| 2023 | 1,179 | 509,789 | $25,891,544 | $9,757,812 | $7,779,088 |
| 2022 | 958 | 422,774 | $15,755,519 | $7,546,049 | $6,011,358 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 50,460 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 39,695 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 34,000 | $56 | $45 |
| J0185 | Injection, aprepitant, 1 mg | 32,370 | $2 | $1 |
| J9299 | Injection, nivolumab, 1 mg | 28,220 | $31 | $25 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 21,500 | $0 | $0 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 20,250 | $1 | $1 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 19,500 | $6 | $4 |
| J0897 | Injection, denosumab, 1 mg | 16,680 | $26 | $20 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 15,048 | $26 | $21 |
| J9267 | Injection, paclitaxel, 1 mg | 13,296 | $0 | $0 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 8,670 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 0428992 | KS |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Kansas
- NPI 1053372649
- NPI 1841251394
- NPI 1821249137
- NPI 1972721348
- NPI 1043272305
- NPI 1336451665
- NPI 1528263043
- NPI 1750777959
See all Hematology & Oncology Physician providers in Kansas →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.